Search Results - "Teshima, C. W."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Maintenance of clinical benefit in Crohn’s disease patients after discontinuation of infliximab: long‐term follow‐up of a single centre cohort by Waugh, A. W. G., Garg, S., Matic, K., Gramlich, L., Wong, C., Sadowski, D. C., Millan, M., Bailey, R., Todoruk, D., Cherry, R., Teshima, C. W., Dieleman, L., Fedorak, R. N.

    Published in Alimentary pharmacology & therapeutics (01-11-2010)
    “…Aliment Pharmacol Ther 2010; 32: 1129–1134 Summary Background  Tumour necrosis factor‐blockade with infliximab has advanced the treatment of Crohn’s disease…”
    Get full text
    Journal Article
  2. 2
  3. 3

    A47 LONG-TERM CLINICAL OUTCOMES AFTER ENDOSCOPIC TREATMENT FOR SMALL BOWEL VACULAR LESIONS BY DOUBLE BALLOON ENDOSCOPY by Hansen, T, Teshima, C W

    “…Abstract Background Balloon-assisted endoscopy (BAE) has revolutionized the approach to obscure GI bleeding (OGIB) by enabling the diagnosis and treatment of…”
    Get full text
    Journal Article
  4. 4

    A223 OPTIMIZING CO-MANAGEMENT OF PANCREATIC ENZYME INSUFFICIENCY: A CANADIAN CONSENSUS by Donnellan, F, Baillargeon, D, Teshima, C W

    “…Abstract Background Pancreatic enzyme insufficiency (PEI) arises from a variety of causes in various pathologic states, including inborn disease (notably…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    A38 CLINICAL OUTCOMES OF PATIENTS UNDERGOING BALLOON-ASSISTED ENDOSCOPY FOR OBSCURE GASTROINTESTINAL BLEEDING by Mazurek, M, Zepeda-Gomez, S, Halloran, B P, Teshima, C W

    “…Abstract Background The etiology of gastrointestinal bleeding remains unclear in a sizable minority of patients despite extensive evaluation. In these…”
    Get full text
    Journal Article
  10. 10
  11. 11